Dr. Thomas Schinecker
Designated CEO Roche Group as of 15 March 2023 and ad interim CEO Roche Pharmaceuticals
About Roche
Our leadership team
View all leaders

Personal Data

Nationality
Austrian and German

Year of Birth
1975

Studies

  • Genetics at University Salzburg, B.A., 1997

  • Molecular Biology at New York University, M.S., 2000

  • Doctorate in Molecular Biology at New York University, Ph.D., 2003

Professional Career

2003-2005
Roche Management Development Program “Perspectives”, Roche Singapore, Basel, Vienna, and Mannheim

2005-2008
Head of Marketing and Sales, Roche Diagnostics Austria, Vienna

2008-2011
General Manager Roche Diagnostics, Sweden, Stockholm

2011-2013
Lifecycle Leader Sequencing Solutions, Roche Diagnostics Branford and Madison

2013-2017
General Manager of Roche Diagnostics Germany, Mannheim, and Roche Holding Germany, Grenzach

January 2018-July 2019
Global Head of Roche Diagnostics Centralized and Point of Care Solutions, Rotkreuz

Since August 2019
CEO Roche Diagnostics, Basel, Switzerland

Other Activities / Memberships

  • Member of the Innovation Board of Labor Berlin (Charité and Vivantes)

Möchten Sie den Inhalt auf Deutsch lesen?

Zur deutschen Version
Zur deutschen Version

Discover more